In Silico
Target Validation
Evaluate how a gene interacts within the molecular mechanisms that drive the cell, tissue functions and phenotypes associated with your disease of interest. Ask Euretos and do days if not weeks of online desk research in minutes. Available as platform subscription or consulting service.
TARGET VALIDATION EXAMPLE
ASK EURETOS
Evaluate all disease related molecular gene interactions
Leverage gene-disease annotations from over 200+ data sources in Euretos. Analyze all molecular interactions of the gene of interest but only where the interactors are disease related. For example differentially expression analysis provides only those genes that interact with the gene of interest and are differentially expressed for the disease
Evaluate target/biomarker suitability on 10 separate criteria
Evaluate 10 key aspects that are relevant to assess a gene as a viable target or biomarker for a disease including healthy expression, differential expression, gene variants, animal models, gene, protein & metabolite interactions, phenotypes, pathways, cell & molecular function and organ & tissue functions.
Latest News
Euretos AI Platform predicts key molecular mechanism for recently identified lung cancer target
Thursday 22 February 2018In a recent study, published in the Oncotarget journal, researchers identified PRC1 as a novel potential target for lung cancer. The study found that tumorigenesis and cell proliferation strongly depend on PRC1 and inhibition of PRC1 significantly ...
Read More....Researchers find further evidence for a genetic link between Crohn's & Parkinson's disease.
Wednesday 24 January 2018In a recent study published in Science - Translational Medicine, researchers found that LRRK2, a known Parkinson’s Disease gene, is also involved in Crohn’s disease. The study found two mutations of the LRRK2 gene in Crohn's disease patients, o ...
Read More....Euretos blog on empowering life science researchers through AI published
Monday 08 January 2018Our blog ‘Big Data Analytics And Artificial Intelligence: 7 Design Principles To Empower Life Science Researchers’ is now available on the Global Engage website. The blog is a summary of the presentation by Arie Baak of Euretos that was held at ...
Read More....
Summary of Target Validation Capabilities
Healthy expression - Healthy RNA (fpkm) and protein expression (abundance) of the gene of interest from 5 expression sources including the identification of key associated tissues for the disease based on literature co-occurrence analysis.
Genetic annotations - Direct disease annotations for the gene of interest and all other disease annotated genes having molecular interaction with the gene of interest.
Differential Expression - Differential expression of the gene of interest and any other differentially expressed gene having molecular interaction with the gene of interest (with log2fold expression level).
Gene variants - Known disease causing mutations for the gene of interest and any other disease variant gene having molecular interaction with the gene of interest.
Animal models - Manipulated genes in animal models of the disease, and their molecular interactions with the gene of interest.
Metabolites - All disease associated metabolites that interact with the gene of interest and all disease associated metabolites that interact with genes having molecular interaction with the gene of interest.
Phenotypes - All phenotypes that are significantly associated with the entire set of genes that have molecular interaction with the gene of interest.
Pathways - All Pathways that are significantly associated with the entire set of genes that have molecular interaction with the gene of interest.
Cell or molecular functions - All cell and molecular functions that are significantly associated with the entire set of genes that have molecular interaction with the gene of interest.
Organ and tissue functions - All organ and tissue functions that are significantly associated with the entire set of genes that have molecular interaction with the gene of interest.